link
Bookmarks
 (0)
Nuclear Medicine
Cardiac
Cardiomyopathy
Cardiac Amyloidosis
Cardiac Amyloidosis
Fathima Fijula P. Manzil, MD
To access 4,300 diagnoses written by the world's leading experts in radiology, please log in or subscribe.Log inSubscribe
0
5
0
0

KEY FACTS

  • Terminology

    • Imaging

      • Diagnostic Checklist

        TERMINOLOGY

        • Definitions

          • Cardiac amyloidosis: Abnormal beta-pleated sheets of protein infiltrating heart
            • Most (> 95%) caused by amyloid light chain (AL) or amyloid transthyretin (ATTR)
            • AL amyloidosis 
              • Plasma cell disorder with overproduction of lambda and kappa light chains that form amyloid deposits; treated with chemotherapy (similar to multiple myeloma, another plasma cell disorder)
            • ATTR amyloidosis
              • Transthyretin protein amyloid deposits; treated with heart transplant when advanced
              • ATTRm (mutant) variant: Point mutations in TTR
              • ATTRwt (wild-type) variant: No TTR mutation
            • Other amyloid types involving heart: Amyloid A, apolipoprotein AI, heavy chain, atrial natriuretic peptide
            • Endomyocardial biopsy gold standard for diagnosis

        IMAGING

        • Nuclear Medicine Findings

          • Imaging Recommendations

            DIFFERENTIAL DIAGNOSIS

              CLINICAL ISSUES

              • Presentation

                • Demographics

                  • Natural History & Prognosis

                    • Treatment

                      DIAGNOSTIC CHECKLIST

                      • Image Interpretation Pearls

                        Selected References

                        1. Bokhari S et al: Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis. J Nucl Cardiol. 25(1):181-90, 2018
                        2. Harb SC et al: National patterns in imaging utilization for diagnosis of cardiac amyloidosis: A focus on Tc99m-pyrophosphate scintigraphy. J Nucl Cardiol. 24(3):1094-1097, 2017
                        3. 99mTechnetium-Pyrophosphate Imaging for Transthyretin Cardiac Amyloidosis. ASNC Practice Points. https://www.asnc.org/Files/Practice%20Resources/Practice%20Points/ASNC%20Practice%20Point-99mTechnetiumPyrophosphateImaging2016.pdf. Published 2016. Accessed July 3, 2019
                        4. Bokhari S et al: Nuclear imaging modalities for cardiac amyloidosis. J Nucl Cardiol. 21(1):175-84, 2014
                        Related Anatomy
                        Loading...
                        Related Differential Diagnoses
                        Loading...
                        References
                        Tables

                        Tables

                        KEY FACTS

                        • Terminology

                          • Imaging

                            • Diagnostic Checklist

                              TERMINOLOGY

                              • Definitions

                                • Cardiac amyloidosis: Abnormal beta-pleated sheets of protein infiltrating heart
                                  • Most (> 95%) caused by amyloid light chain (AL) or amyloid transthyretin (ATTR)
                                  • AL amyloidosis 
                                    • Plasma cell disorder with overproduction of lambda and kappa light chains that form amyloid deposits; treated with chemotherapy (similar to multiple myeloma, another plasma cell disorder)
                                  • ATTR amyloidosis
                                    • Transthyretin protein amyloid deposits; treated with heart transplant when advanced
                                    • ATTRm (mutant) variant: Point mutations in TTR
                                    • ATTRwt (wild-type) variant: No TTR mutation
                                  • Other amyloid types involving heart: Amyloid A, apolipoprotein AI, heavy chain, atrial natriuretic peptide
                                  • Endomyocardial biopsy gold standard for diagnosis

                              IMAGING

                              • Nuclear Medicine Findings

                                • Imaging Recommendations

                                  DIFFERENTIAL DIAGNOSIS

                                    CLINICAL ISSUES

                                    • Presentation

                                      • Demographics

                                        • Natural History & Prognosis

                                          • Treatment

                                            DIAGNOSTIC CHECKLIST

                                            • Image Interpretation Pearls

                                              Selected References

                                              1. Bokhari S et al: Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis. J Nucl Cardiol. 25(1):181-90, 2018
                                              2. Harb SC et al: National patterns in imaging utilization for diagnosis of cardiac amyloidosis: A focus on Tc99m-pyrophosphate scintigraphy. J Nucl Cardiol. 24(3):1094-1097, 2017
                                              3. 99mTechnetium-Pyrophosphate Imaging for Transthyretin Cardiac Amyloidosis. ASNC Practice Points. https://www.asnc.org/Files/Practice%20Resources/Practice%20Points/ASNC%20Practice%20Point-99mTechnetiumPyrophosphateImaging2016.pdf. Published 2016. Accessed July 3, 2019
                                              4. Bokhari S et al: Nuclear imaging modalities for cardiac amyloidosis. J Nucl Cardiol. 21(1):175-84, 2014
                                              Contact UsStoreTerms and ConditionsRegistered User AgreementPrivacy PolicyHelp